Public release date: 8-Feb-2012
[ | E-mail | Share ] <\/p>\n
Contact: Cathia Falvey New Rochelle, NY, February 8, 2012?Chronic neuropathic pain following a spinal cord injury is common and very difficult to treat, but a new therapeutic strategy requiring a one-time injection into the spinal column has potential to improve patient outcomes. This cutting-edge pain management strategy is described in an article published in Journal of Neurotrauma, a peer-reviewed journal from Mary Ann Liebert, Inc. The article is available free online at http:\/\/www.liebertpub.com\/neu<\/a>, along with a related article on pain following spinal cord injury. <\/p>\n A single injection of fibronectin, a glycoprotein produced in the body that helps anchor cells in place, can prevent the development of chronic pain that often develops after a spinal cord injury. Ching-Yi Lin, Yu-Shang Lee, Vernon Lin and Jerry Silver, from the Lerner Research Institute, Cleveland Clinic, and Case Western Reserve University, in Cleveland, OH, describe the successful outcome following injection of a small quantity of fibronectin into the spinal dorsal column of animals immediately after a spinal dorsal column crush injury. The treatment inhibits the development of a particular type of chronic pain?mechanical allodynia, or pain from pressure that would not normally cause pain?which is common in spinal cord injury patients. The authors report their findings in the article \"Fibronectin Inhibits Chronic Pain Development after Spinal Cord Injury.\" <\/p>\n Changes that occur outside the central nervous system can also play a role in the development of chronic pain after spinal cord injury. Another article in the Journal by Supinder Bedi and colleagues, University of Texas Medical School at Houston, reports that a type of nerve cell present in the peripheral nervous system, called a nociceptive primary afferent neuron, is hyperexcitable and displays spontaneous activity after spinal cord injury, which might be important for the development of chronic pain. They present their findings in the article \"Spinal Cord Injury Triggers an Intrinsic Growth-Promoting State in Nociceptors.\" <\/p>\n \"These highlighted experimental studies provide new information on mechanisms underlying the development of neuropathic pain and potential therapeutic interventions to treat pain after spinal cord injury,\" says Deputy Editor of Journal of Neurotrauma, W. Dalton Dietrich III, PhD, Scientific Director, The Miami Project to Cure Paralysis, and Kinetic Concepts Distinguished Chair in Neurosurgery, Professor of Neurological Surgery, Neurology and Cell Biology at University of Miami Leonard M. Miller School of Medicine, Lois Pope LIFE Center. <\/p>\n ### <\/p>\n Journal of Neurotrauma is an authoritative peer-reviewed journal published 18 times per year in print and online that focuses on the latest advances in the clinical and laboratory investigation of traumatic brain and spinal cord injury. Emphasis is on the basic pathobiology of injury to the nervous system, and the papers and reviews evaluate preclinical and clinical trials targeted at improving the early management and long-term care and recovery of patients with traumatic brain injury. Journal of Neurotrauma is the Official Journal of the National Neurotrauma Society and the International Neurotrauma Society. Complete tables of content and a sample issue may be viewed online at http:\/\/www.liebertpub.com\/neu<\/a> <\/p>\n Mary Ann Liebert, Inc. is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Therapeutic Hypothermia and Temperature Management, Tissue Engineering, and Brain Connectivity. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 70 journals, books, and newsmagazines is available at http:\/\/www.liebertpub.com<\/a> <\/p>\n Mary Ann Liebert, Inc. 140 Huguenot St., New Rochelle, NY 10801-5215 [ | E-mail | Share ] <\/p>\n <\/p>\n AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system. <\/p>\n <\/p>\n See more here: Public release date: 8-Feb-2012 [ | E-mail | Share ] Contact: Cathia Falvey cfalvey@liebertpub.com<\/a> 914-740-2100 Mary Ann Liebert, Inc.\/Genetic Engineering News New Rochelle, NY, February 8, 2012?Chronic neuropathic pain following a spinal cord injury is common and very difficult to treat, but a new therapeutic strategy requiring a one-time injection into the spinal column has potential to improve patient outcomes. This cutting-edge pain management strategy is described in an article published in Journal of Neurotrauma, a peer-reviewed journal from Mary Ann Liebert, Inc. The article is available free online at http:\/\/www.liebertpub.com\/neu<\/a>, along with a related article on pain following spinal cord injury. Continue reading
cfalvey@liebertpub.com<\/a>
914-740-2100
Mary Ann Liebert, Inc.\/Genetic Engineering News <\/p>\n
Phone: (914) 740-2100 (800) M-LIEBERT Fax: (914) 740-2101
http:\/\/www.liebertpub.com<\/a> <\/p>\n
\nNew treatment for chronic pain after spinal cord injury<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"